BREWIN DOLPHIN WEALTH MANAGEMENT LTD - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 16 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN WEALTH MANAGEMENT LTD ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2017$6
+20.0%
100.0%0.00%
Q3 2017$5100.00%
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q4 2017.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders